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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S16outcomes using the following independent variables: 1) sex; 2) sex
and age; 3) sex, age and pre-surgery score of the outcome; and, 4) the
latter model plus BMI, education level, low back pain (LBP), depres-
sion, number of comorbidities, and symptomatic joint count. P values
of  0.05 were considered signiﬁcant. As change between 6 and 12
months surgery is known to be much less relative to baseline to 6
months, we conducted analyses at 12 months as a validation of the 6
month results.
Results: The sample included 323 females and 171 males. Females had
worse pain and function scores at baseline compared to males (pain:
39.0  16.5 in females versus 44.9  16.4 in males, p¼0.002; function:
47.7  18.6 in females versus 55.0  17.5 in males, p<0.0001). As well,
females had worse pain and function at follow-up (72.218.4 vs. 76.1
17.7, p¼0.03; 75.2  17.5 vs 80.5  17.1, p¼0.003, respectively). Females
also had worse pre-surgery depression scores (5.6  3.6 vs 4.7  3.2,
p¼0.006), higher rates of obesity (BMI >30: 54.2 vs. 36.3%, p¼0.0002),
and higher symptomatic joint count (>4: 61.3 vs. 44.4%, p¼0.0004).
Initially, regression ﬁndings suggested that females had worse out-
comes for pain (p¼0.04) and function (p¼0.007) compared to males.
However, this effect was lost once baseline pain/functional status were
also considered. In the ﬁnal model, worse outcomes were predicted by
pre-surgery pain/functional status, as well as depression, LBP and
comorbidity count. The results at 12months were consistent with those
at 6 months.
Conclusions: Women appear to have worse outcomes following TKR in
part as a function of their greater pain and more limited function pre-
surgery. However, depression and comorbidity, for which women have
worse status pre-surgery, further contribute to worse outcomes. These
ﬁnding suggest that women potentially could achieve comparable
outcomes tomen if surgery were performed before their symptoms and
disability became so severe. This could, in addition, limit the effect of
mood or, alternately, interventions to address mood could positively
inﬂuence outcomes.
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IDENTIFICATION OF SEROLOGICAL PROFILES ASSOCIATED WITH
TOTAL JOINT REPLACEMENT IN OSTEOARTHRITIS PATIENTS
R.H. Arends y, M.A. Karsdal z, A.C. Bay-Jensen z, D.S. Keller y. y Pﬁzer,
Groton, CT, USA; zNordic BioSci., Herlev, Denmark
Purpose: 1. To identify patients who will progress to requiring total
joint replacement (TJR) amongst a populationwith moderate-to severe-
osteoarthritis (OA) by measuring tissue speciﬁc biomarkers in serum
thus establishing a panel of prognostic biomarkers that may provide
molecular insight into the mechanism and pathology of the progression
of OA. 2. Investigate the effect of NSAIDs on the predictive and diag-
nostic serum proﬁle.
Methods: OA patients were randomly selected from clinical trials
investigating the anti-NGF therapeutic antibody tanezumab. Serum
samples from 240 patients who underwent a TJR (cases) and from 440
control OA patients who did not undergo TJR were used. Control group
consisted of w2 patients per case matched on: age (<65 or  65
years), Kellgren-Lawrence (K-L) grade, gender, BMI category (<30 or
30 kg/m2), OA severity (severe if both WOMAC Pain and Physical
function subscale scores were 7 and the Patient Global Assessment
score was 4 (i.e. Poor or Very Poor), otherwise baseline OA severity
was classiﬁed as not severe). On the average, the OA population was 62
years old, 80% K-L grade 3, females (68%), BMI w31 kg/m2, WOMAC
pain score of 7. Serum samples were analyzed for bone (Total Osteo-
calcin, CTX-I, DKK1, SOST), cartilage (C2M, COMP, PIIANP), connective
tissue (PINP, ICTP, C1M), synovial tissue (C3M), protease burden (MMP-
9) as well as inﬂammation markers (IL6, hsCRP, VEGF). Classiﬁcation
and Regression Tree analysis was used to identify biomarker
phenotypes.
Results: For NSAID and non-NSAID users separately, biomarker phe-
notypes were identiﬁed at baseline for patients predisposed for TJR. At
baseline, a biomarker combination for patients who used NSAIDs before
start of tanezumab clinical trials identiﬁed 96% of patients who
underwent a TJR and 61% of the patients who did not undergo a TJR.
Identiﬁcation of these biomarker phenotypes lowers the odds of a TJR
by 14-fold as compared to not having knowledge of the biomarkers. For
patients who did not use NSAIDs, 83% of patients who had a TJR and 63%
of the patients who did not undergo a TJR, were identiﬁed which lowers
the odds of a TJR by 3.6-fold. For patients who used NSAIDs con-
tinuously, 84% of patients who had a TJR and 77% of the patients whodid not have a TJR, were identiﬁed which lowers the odds of a TJR by
4.7-fold.
Conclusions: Serological biomarker proﬁles for predicting TJR were
identiﬁed irrespective of NSAID use and may assist in identifying
those patients whom will need a TJR. The proﬁles also suggest that
NSAID use increases the importance of the role of bone metabolism
in TJR pathology. The results need validation on other cohorts, and
may ﬁnally provide value to patients and payers in selecting the
most optimal treatment strategy for moderate-to-severe OA
patients.
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MALES ARE AT INCREASED RISK FOR SURGICAL COMPLICATIONS
FOLLOWING TOTAL JOINT ARTHOPLASTY
B. Ravi y, R. Croxford z, T. Leroux y, S. Hollands z, G. Hawker y. yUniv. of
Toronto, Toronto, ON, Canada; z Inst. for Clinical Evaluative Sci. (ICES),
Toronto, ON, Canada
Purpose: The burden of osteoarthritis of the hip and knee is higher
in females than in males. Despite this, there remains a gender dis-
parity in the recommendation and uptake of total joint arthroplasty
(TJA), with males being more likely to be offered surgery. This may
result from a perception that females have a higher rate of compli-
cations, including: acute myocardial infarction (AMI), venous
thrombo-embolism (VTE), infection, dislocation, early revision, and
death. To date, few studies have examined if differences by sex
persist in the rates of complications following TJA of the hip (THA) or
knee (TKA).
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective THA or TKA between 2002-2009 utilizing admin-
istrative databases from Ontario, Canada. We excluded those who
received a primary or revision arthroplasty of the hip or knee prior to
April 1, 2002, those whose ﬁrst procedure was non-elective (e.g. for
cancer, fracture, or injury), or those with a history of hip dysplasia. We
compared baseline characteristics and rates of complications follow-
ing the index TJA for male and female recipients. Cox proportional
hazards were used to determine the relationship between sex and the
occurrence of speciﬁc complications (within 90d: VTE, AMI, mortality;
within 2y: dislocation, infection, and revision), deﬁned using vali-
dated algorithms, controlling for potential confounders (including
income quintile, rurality, and provider volume) and for clustering by
surgeons.
Results: Between April 1, 2002 and March 31, 2009, there were 97,445
patients who received their ﬁrst TJA (males: 41,023 - 42%; females:
56,422 - 58%). Compared with female TJA recipients, males were more
likely to have received a THA (43% versus 36%, p<0.001), more likely to
come from a rural area (20% versus 15%, p<0.001), and had greater co-
morbidity (Charlson score of 2þ: 5.5% vs 3.5%, p<0.001). Controlling for
these differences, and other potential confounders, male TJA recipients
were more likely to experience an infection (adjusted HR 1.41, 95%CI
1.24-1.61, p<0.0001), early revision (adjusted HR 1.24, 95%CI 1.10-1.40,
p¼0.0006), or death (adjusted HR 1.26, 95%CI 1.03-1.55, p¼0.03). They
were similarly likely to experience all other complications: dislocation
(adjusted HR 0.94, 95%CI 0.79-1.12, p¼0.48), AMI (adjusted HR 1.05, 95%
CI 0.93-1.19, p¼0.41), and VTE (adjusted HR 0.99, 95%CI 0.88-1.12,
p¼0.95).
Conclusions: In a population cohort undergoing their ﬁrst primary TJA,
male recipients were at increased risk for early revision, infection and
death relative to female recipients.
20
BMP2 REQUIRES TGF-BETA TO INDUCE OSTEOPHYTES DURING
EXPERIMENTAL OA
E.N. Blaney Davidson, E.L. Vitters, A.B. Blom, A.P. van Caam,
M.B. Bennink, W.B. van den Berg, F.A. van de Loo, P.M. van der Kraan.
Radboud Univ. Med. Ctr., Nijmegen, Netherlands
Purpose: Osteophyte formation is one of the hallmarks of osteo-
arthritis (OA). We have shown that either overexpression of TGF-beta
or BMP2 can induce osteophytes in murine knee joints. However,
comparing osteophytes induced by experimental OA, TGF-beta or
BMP2 showed us that TGF-beta-induced osteophytes rather than
BMP2-induced osteophytes more closely resemble those observed in
experimental OA. TGF-beta-induced osteophytes develop mainly from
